Hans Christian Hagedorn
Danish physician and biochemist
Hans Christian Hagedorn (6 September 1888 – 6 October 1971) was a Danish physician and biochemist renowned for his pioneering work in the field of diabetes treatment. He is best known for co-discovering the insulin-stabilizing compound protamine and for founding the Nordisk Insulinlaboratorium, which later became part of Novo Nordisk, a leading global healthcare company.
Early Life and Education[edit | edit source]
Hans Christian Hagedorn was born in Copenhagen, Denmark. He pursued his medical studies at the University of Copenhagen, where he developed a keen interest in biochemistry and endocrinology. After completing his medical degree, Hagedorn continued his research in the field of diabetes, which was a major health concern at the time.
Career and Research[edit | edit source]
Hagedorn's career was marked by significant contributions to the understanding and treatment of diabetes. In the early 1920s, he collaborated with August Krogh, a Nobel laureate, to establish the Nordisk Insulinlaboratorium. This institution was instrumental in the production and distribution of insulin in Scandinavia.
Discovery of Protamine Insulin[edit | edit source]
One of Hagedorn's most notable achievements was the discovery of protamine insulin. In collaboration with the Canadian scientist James Bertram Collip, Hagedorn found that the addition of protamine, a protein, to insulin could prolong its action in the body. This discovery led to the development of NPH (Neutral Protamine Hagedorn) insulin, which became a standard treatment for diabetes and is still widely used today.
Legacy[edit | edit source]
Hagedorn's work had a profound impact on the treatment of diabetes, improving the quality of life for millions of patients worldwide. His contributions to medical science were recognized with numerous awards and honors throughout his career. The Hagedorn Research Institute, named in his honor, continues to advance research in diabetes and related fields.
Related Pages[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
|
WikiMD's Wellness Encyclopedia |
| Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD
